STRIDES PHARMA SCIENCE
|
STRIDES PHARMA SCIENCE Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr |
Equity - Authorised | ₹188 Cr | ₹188 Cr | ₹188 Cr | ₹177 Cr | ₹177 Cr |
Equity - Issued | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr |
Equity Paid Up | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹19 Cr | ₹2.45 Cr | ₹4.72 Cr | ₹5.72 Cr | ₹7.57 Cr |
Total Reserves | ₹2,103 Cr | ₹2,267 Cr | ₹2,682 Cr | ₹2,432 Cr | ₹2,552 Cr |
Securities Premium | ₹1,754 Cr | ₹1,732 Cr | ₹1,727 Cr | ₹1,701 Cr | ₹1,700 Cr |
Capital Reserves | ₹36 Cr | ₹34 Cr | ₹21 Cr | ₹43 Cr | ₹57 Cr |
Profit & Loss Account Balance | ₹-200 Cr | ₹2.31 Cr | ₹485 Cr | ₹234 Cr | ₹381 Cr |
General Reserves | ₹404 Cr | ₹404 Cr | ₹402 Cr | ₹401 Cr | ₹398 Cr |
Other Reserves | ₹109 Cr | ₹95 Cr | ₹47 Cr | ₹53 Cr | ₹15 Cr |
Reserve excluding Revaluation Reserve | ₹2,103 Cr | ₹2,267 Cr | ₹2,682 Cr | ₹2,432 Cr | ₹2,552 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,212 Cr | ₹2,359 Cr | ₹2,777 Cr | ₹2,527 Cr | ₹2,649 Cr |
Minority Interest | ₹-39 Cr | ₹24 Cr | ₹37 Cr | ₹67 Cr | ₹153 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹1,041 Cr | ₹745 Cr | ₹873 Cr | ₹602 Cr | ₹1,806 Cr |
Non Convertible Debentures | ₹121 Cr | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹1,042 Cr | ₹1,117 Cr | ₹978 Cr | ₹731 Cr | ₹1,880 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-122 Cr | ₹-372 Cr | ₹-104 Cr | ₹-129 Cr | ₹-74 Cr |
Unsecured Loans | ₹99 Cr | ₹91 Cr | ₹9.15 Cr | ₹2.12 Cr | ₹0.06 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | ₹3.88 Cr | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹102 Cr | ₹94 Cr | ₹5.30 Cr | ₹2.14 Cr | ₹0.08 Cr |
Other Unsecured Loan | ₹-3.04 Cr | ₹-3.59 Cr | ₹-0.03 Cr | ₹-0.02 Cr | ₹-0.02 Cr |
Deferred Tax Assets / Liabilities | ₹-220 Cr | ₹-179 Cr | ₹-152 Cr | ₹-178 Cr | ₹33 Cr |
Deferred Tax Assets | ₹326 Cr | ₹295 Cr | ₹262 Cr | ₹278 Cr | ₹237 Cr |
Deferred Tax Liability | ₹106 Cr | ₹116 Cr | ₹110 Cr | ₹100 Cr | ₹269 Cr |
Other Long Term Liabilities | ₹218 Cr | ₹245 Cr | ₹287 Cr | ₹324 Cr | ₹451 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹73 Cr | ₹64 Cr | ₹246 Cr | ₹64 Cr | ₹52 Cr |
Total Non-Current Liabilities | ₹1,210 Cr | ₹966 Cr | ₹1,264 Cr | ₹814 Cr | ₹2,343 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹982 Cr | ₹1,072 Cr | ₹1,134 Cr | ₹798 Cr | ₹889 Cr |
Sundry Creditors | ₹982 Cr | ₹1,072 Cr | ₹1,134 Cr | ₹798 Cr | ₹889 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹528 Cr | ₹697 Cr | ₹421 Cr | ₹354 Cr | ₹248 Cr |
Bank Overdraft / Short term credit | - | - | - | - | ₹0.01 Cr |
Advances received from customers | ₹32 Cr | ₹28 Cr | ₹24 Cr | ₹31 Cr | ₹44 Cr |
Interest Accrued But Not Due | - | - | - | ₹10 Cr | ₹20 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹495 Cr | ₹669 Cr | ₹397 Cr | ₹313 Cr | ₹184 Cr |
Short Term Borrowings | ₹1,331 Cr | ₹1,497 Cr | ₹1,024 Cr | ₹1,229 Cr | ₹1,339 Cr |
Secured ST Loans repayable on Demands | ₹1,227 Cr | ₹1,364 Cr | ₹962 Cr | ₹1,224 Cr | ₹1,240 Cr |
Working Capital Loans- Sec | ₹956 Cr | ₹1,013 Cr | ₹681 Cr | ₹714 Cr | ₹891 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-851 Cr | ₹-881 Cr | ₹-619 Cr | ₹-710 Cr | ₹-792 Cr |
Short Term Provisions | ₹149 Cr | ₹146 Cr | ₹159 Cr | ₹164 Cr | ₹186 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹27 Cr | ₹24 Cr | ₹35 Cr | ₹38 Cr | ₹58 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹122 Cr | ₹123 Cr | ₹124 Cr | ₹126 Cr | ₹128 Cr |
Total Current Liabilities | ₹2,990 Cr | ₹3,412 Cr | ₹2,738 Cr | ₹2,545 Cr | ₹2,662 Cr |
Total Liabilities | ₹6,373 Cr | ₹6,761 Cr | ₹6,817 Cr | ₹5,953 Cr | ₹7,807 Cr |
ASSETS | |||||
Gross Block | ₹3,325 Cr | ₹3,232 Cr | ₹2,841 Cr | ₹2,534 Cr | ₹4,049 Cr |
Less: Accumulated Depreciation | ₹1,026 Cr | ₹898 Cr | ₹690 Cr | ₹509 Cr | ₹479 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹2,298 Cr | ₹2,333 Cr | ₹2,151 Cr | ₹2,026 Cr | ₹3,570 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹48 Cr | ₹56 Cr | ₹228 Cr | ₹148 Cr | ₹100 Cr |
Non Current Investments | ₹439 Cr | ₹540 Cr | ₹598 Cr | ₹430 Cr | ₹417 Cr |
Long Term Investment | ₹439 Cr | ₹540 Cr | ₹598 Cr | ₹430 Cr | ₹417 Cr |
Quoted | ₹2.08 Cr | ₹4.78 Cr | ₹14 Cr | ₹0.98 Cr | ₹11 Cr |
Unquoted | ₹445 Cr | ₹544 Cr | ₹592 Cr | ₹429 Cr | ₹406 Cr |
Long Term Loans & Advances | ₹217 Cr | ₹211 Cr | ₹186 Cr | ₹211 Cr | ₹224 Cr |
Other Non Current Assets | ₹12 Cr | ₹10 Cr | ₹549 Cr | ₹428 Cr | ₹17 Cr |
Total Non-Current Assets | ₹3,130 Cr | ₹3,399 Cr | ₹4,000 Cr | ₹3,581 Cr | ₹4,758 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹51 Cr | - | ₹99 Cr | ₹119 Cr | ₹285 Cr |
Quoted | - | - | - | - | ₹154 Cr |
Unquoted | ₹51 Cr | - | ₹99 Cr | ₹119 Cr | ₹130 Cr |
Inventories | ₹1,147 Cr | ₹1,174 Cr | ₹1,201 Cr | ₹783 Cr | ₹874 Cr |
Raw Materials | ₹522 Cr | ₹575 Cr | ₹552 Cr | ₹507 Cr | ₹415 Cr |
Work-in Progress | ₹51 Cr | ₹48 Cr | ₹39 Cr | ₹61 Cr | ₹59 Cr |
Finished Goods | ₹439 Cr | ₹278 Cr | ₹536 Cr | ₹183 Cr | ₹180 Cr |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | ₹27 Cr | ₹23 Cr | ₹22 Cr | ₹18 Cr | ₹14 Cr |
Other Inventory | ₹108 Cr | ₹250 Cr | ₹52 Cr | ₹15 Cr | ₹207 Cr |
Sundry Debtors | ₹1,299 Cr | ₹1,207 Cr | ₹1,111 Cr | ₹932 Cr | ₹987 Cr |
Debtors more than Six months | ₹299 Cr | ₹240 Cr | ₹95 Cr | - | - |
Debtors Others | ₹1,046 Cr | ₹1,010 Cr | ₹1,077 Cr | ₹1,000 Cr | ₹1,061 Cr |
Cash and Bank | ₹316 Cr | ₹187 Cr | ₹180 Cr | ₹237 Cr | ₹517 Cr |
Cash in hand | ₹0.27 Cr | ₹0.27 Cr | ₹0.30 Cr | ₹0.24 Cr | ₹0.27 Cr |
Balances at Bank | ₹261 Cr | ₹175 Cr | ₹160 Cr | ₹228 Cr | ₹479 Cr |
Other cash and bank balances | ₹55 Cr | ₹12 Cr | ₹19 Cr | ₹8.84 Cr | ₹38 Cr |
Other Current Assets | ₹169 Cr | ₹648 Cr | ₹98 Cr | ₹82 Cr | ₹137 Cr |
Interest accrued on Investments | ₹1.33 Cr | ₹0.12 Cr | ₹3.98 Cr | ₹3.85 Cr | ₹2.51 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹7.39 Cr | ₹2.90 Cr | ₹1.42 Cr | ₹1.31 Cr | ₹2.67 Cr |
Prepaid Expenses | ₹64 Cr | ₹54 Cr | ₹53 Cr | ₹48 Cr | ₹36 Cr |
Other current_assets | ₹97 Cr | ₹591 Cr | ₹40 Cr | ₹28 Cr | ₹95 Cr |
Short Term Loans and Advances | ₹153 Cr | ₹145 Cr | ₹129 Cr | ₹218 Cr | ₹249 Cr |
Advances recoverable in cash or in kind | ₹57 Cr | ₹57 Cr | ₹34 Cr | ₹106 Cr | ₹114 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹97 Cr | ₹88 Cr | ₹95 Cr | ₹113 Cr | ₹135 Cr |
Total Current Assets | ₹3,135 Cr | ₹3,362 Cr | ₹2,817 Cr | ₹2,371 Cr | ₹3,049 Cr |
Net Current Assets (Including Current Investments) | ₹145 Cr | ₹-50 Cr | ₹79 Cr | ₹-174 Cr | ₹386 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹6,373 Cr | ₹6,761 Cr | ₹6,817 Cr | ₹5,953 Cr | ₹7,807 Cr |
Contingent Liabilities | ₹632 Cr | ₹834 Cr | ₹844 Cr | ₹2,379 Cr | ₹3,316 Cr |
Total Debt | ₹2,774 Cr | ₹2,792 Cr | ₹2,103 Cr | ₹1,962 Cr | ₹3,219 Cr |
Book Value | - | 262.48 | 309.09 | 281.55 | 294.94 |
Adjusted Book Value | 242.83 | 262.48 | 309.09 | 281.55 | 294.94 |
Compare Balance Sheet of peers of STRIDES PHARMA SCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
STRIDES PHARMA SCIENCE | ₹7,756.8 Cr | 0.5% | -4.2% | 183.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,015.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,809.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,408.7 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹98,684.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,213.7 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
STRIDES PHARMA SCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
STRIDES PHARMA SCIENCE | 0.5% |
-4.2% |
183.8% |
SENSEX | -2.9% |
-0.4% |
20% |
You may also like the below Video Courses